Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a core outcome set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a modified Delphi study.

Journal of neuro-oncology·2026
Same author

Postdischarge outcomes of nonoperative management in complicated diverticulitis: Solution or Band-Aid?

Surgery·2026
Same author

Expanding Procedural Metrics: Rib Fixation as an Additional Surrogate of Trauma Center Performance.

Journal of the American College of Surgeons·2026
Same author

Pediatric sinogenic and otogenic intracranial infections requiring neurosurgical intervention: a North American multicenter study in the era of COVID-19.

Journal of neurosurgery. Pediatrics·2026
Same author

A nationwide comparison of intracranial pressure monitoring devices in pediatric severe traumatic brain injury: Impact on surgical intervention and mortality.

The journal of trauma and acute care surgery·2026
Same author

Geriatric trauma coagulation profiles: Impact of sex on clot formation.

The journal of trauma and acute care surgery·2026
Same journal

Learning Surgery's Moral Questions: Mentorship, Reflection, and Professional Formation.

The American surgeon·2026
Same journal

Complete Response of Merkel Cell Carcinoma to Immunotherapy and Single-Fraction Radiotherapy Following Severe COVID-19 Infection: A Case Report and Review of Immune Mechanism.

The American surgeon·2026
Same journal

Perioperative Acute Myocardial Infarction in Non-Cardiac Operations: A National Analysis.

The American surgeon·2026
Same journal

Outcomes of Completion Cholecystectomy: Association With Patient Comorbidity in a National Database.

The American surgeon·2026
Same journal

Building the Conversation: Editorial Stewardship in Contemporary Surgical Publishing.

The American surgeon·2026
Same journal

Musculoskeletal Pain in Surgeons on Operating Days.

The American surgeon·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
11:49

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model

Published on: September 9, 2011

Prosthetic vascular conduit in contaminated fields: a new technology to decrease ePTFE infections.

Peter E Fischer1, Timothy C Fabian, Waldemar G deRijk

  • 1College of Medicine, Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

The American Surgeon
|June 18, 2008
PubMed
Summary
This summary is machine-generated.

This study shows that minocycline and rifampin bound to ePTFE grafts resist infection from Staph aureus and Staph epidermidis for up to two weeks, offering a promising solution for vascular reconstruction.

More Related Videos

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
11:17

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Published on: April 3, 2015

Wet Chemistry and Peptide Immobilization on Polytetrafluoroethylene for Improved Cell-adhesion
06:15

Wet Chemistry and Peptide Immobilization on Polytetrafluoroethylene for Improved Cell-adhesion

Published on: August 15, 2016

Related Experiment Videos

Last Updated: Jul 4, 2026

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
11:49

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model

Published on: September 9, 2011

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
11:17

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Published on: April 3, 2015

Wet Chemistry and Peptide Immobilization on Polytetrafluoroethylene for Improved Cell-adhesion
06:15

Wet Chemistry and Peptide Immobilization on Polytetrafluoroethylene for Improved Cell-adhesion

Published on: August 15, 2016

Area of Science:

  • Biomaterials Science
  • Infectious Disease Research
  • Vascular Surgery

Background:

  • Vascular reconstruction in contaminated settings risks infection and graft failure.
  • Prosthetic graft infections can lead to severe complications, including amputation.

Purpose of the Study:

  • To evaluate minocycline and rifampin bound to ePTFE grafts for infection resistance.
  • To assess controlled antibiotic elution from methacrylate-bound grafts.

Main Methods:

  • Kirby Bauer susceptibility testing with Staph aureus (SA) and Staph epidermidis (SE).
  • Antibiotic-coated (ABX) grafts tested in vitro with water bath and pulsatile flow.
  • High-performance liquid chromatography with mass spectroscopy (HPLC-MS) for elution analysis.

Main Results:

  • ABX grafts demonstrated significant zones of inhibition (ZIH) against SA (35 mm) and SE (44 mm).
  • After 1 week, ZIH remained substantial (23 mm for both bacteria).
  • HPLC-MS showed 50% antibiotic retention at 24 hours with sustained elution for 7 days.

Conclusions:

  • Methacrylate technology effectively binds minocycline and rifampin to ePTFE grafts.
  • These antibiotic-eluting grafts provide in vitro resistance to SA and SE for up to two weeks.
  • This approach may reduce infection rates in vascular reconstructions.